Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 2009;40:e6
Published online before print November 26, 2008, doi: 10.1161/STROKEAHA.108.539163
This Article
Right arrow Extract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
40/1/e6    most recent
STROKEAHA.108.539163v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bokura, H.
Right arrow Articles by Yamaguchi, S.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Bokura, H.
Right arrow Articles by Yamaguchi, S.

(Stroke. 2009;40:e6.)
© 2009 American Heart Association, Inc.


Letters to the Editor

Response to Letter by Park and Yasuda

Hirokazu Bokura, MD Shuhei Yamaguchi, MD

Department of Neurology, Faculty of Medicine, Shimane University, Izumo, Japan

Response:

We thank Drs Park and Yasuda for their interesting comments. They pointed out the importance of using MRI FLAIR images to diagnose leukoaraiosis (LA). In fact, we also used FLAIR images to evaluate periventricular hyperintensities (PVH) and subcortical white matter lesions (SWML).1 It is important to note that the LA in the study of Park et al2 included both PVH and SWML. Moreover, we evaluated PVH and SWML separately because of differences in their locations and underlying pathology, depending on their severity.3

We re-examined the association between metabolic syndrome (MetS) and PVH and SWML, including minimal LA. The logistic analysis adjusted for age, gender, and smoking revealed that MetS was not associated with minimal PVH (OR=0.80, 95% CI: 0.48 to 1.29 for PVH grade 1; OR=1.14, 95% CI: 0.65 to 2.00 for PVH grade 2). Furthermore, MetS was not associated with minimal SWML (OR=0.94, 95% CI: 0.58 to 1.52 for SWML grade 1). Therefore, our study disagreed with theirs. More data and longitudinal studies are required to determine whether minimal LA is related to MetS.

Acknowledgments

Disclosures

None.

References

1. Bokura H, Yamaguchi S, Iijima K, Iijima K, Nagai A, Oguro H. Metabolic syndrome is associated with silent ischemic brain lesions. Stroke. 2008; 39: 1607–1609.[Abstract/Free Full Text]

2. Park K, Yasuda N, Toyonaga S, Yamada SM, Nakabayashi H, Nakasato M, Nakagomi T, Tsubosaki E, Shimizu K. Significant association between leukoaraiosis and metabolic syndrome in healthy subjects. Neurology. 2007; 69: 974–978.[Abstract/Free Full Text]

3. Fazekas F, Kleinert R, Offenbacher H, Schmidt R, Kleinert G, Payer F, Radner H, Lechner H. Pathologic correlates of incidental MRI white matter signal hyperintensities. Neurology. 1993; 43: 1683–1689.[Abstract/Free Full Text]





This Article
Right arrow Extract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
40/1/e6    most recent
STROKEAHA.108.539163v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bokura, H.
Right arrow Articles by Yamaguchi, S.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Bokura, H.
Right arrow Articles by Yamaguchi, S.